Operating Lease, Right-of-Use Asset of Moleculin Biotech, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Moleculin Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Moleculin Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $343,000, a 24% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Moleculin Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $343,000 -$107,000 -24% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $370,000 -$105,000 -22% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $398,000 -$102,000 -20% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $424,000 -$100,000 -19% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $450,000 -$97,000 -18% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $475,000 +$117,000 +33% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $500,000 +$119,000 +31% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $524,000 +$121,000 +30% 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q3 2023 $547,000 +$122,000 +29% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $358,000 -$88,000 -20% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $381,000 +$300,000 +370% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $403,000 +$296,000 +277% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q3 2022 $425,000 +$294,000 +224% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $446,000 +$291,000 +188% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $81,000 -$98,000 -55% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $107,000 -$95,000 -47% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $131,000 -$93,000 -42% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $155,000 -$90,000 -37% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $179,000 -$87,000 -33% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $202,000 -$85,000 -30% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $224,000 -$82,000 -27% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $245,000 +$142,000 +138% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $266,000 +$160,000 +151% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $287,000 31 Dec 2019 10-K 24 Mar 2021 2020 FY
Q3 2019 $306,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $103,000 30 Jun 2019 10-Q 16 Aug 2019 2019 Q2
Q1 2019 $106,000 31 Mar 2019 10-Q 13 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.